Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
9.15
-0.02 (-0.22%)
Nov 16, 2026, 4:00 PM EST - Market closed

Viemed Healthcare Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
310.37270.28224.26183.01138.83117.06
Revenue Growth
21.81%20.52%22.54%31.82%18.60%-10.85%
Gross Profit
178.17155.46133.2112.7884.6873.41
Operating Income
25.9621.8317.2514.988.410.53
Net Income
15.6214.9311.2710.246.229.13
Earnings Per Share
0.380.370.280.250.160.22
EPS Growth
11.95%32.14%12.00%56.25%-27.27%-71.80%

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.6813.517.5412.8416.9128.41
Total Debt
9.2815.956.8710.320.696.72
Net Cash (Debt)
0.39-2.4510.672.5216.2221.69
Net Cash Growth
--324.41%-84.49%-25.22%11.73%
Net Cash Per Share
0.01-0.060.260.060.410.53

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
53.951.9239.0945.2127.7522.49
Capital Expenditures
-32.53-39.99-37.77-26.09-22.9-19.74
Free Cash Flow
21.3811.931.3219.124.852.75
Free Cash Flow Growth
296.95%805.24%-93.11%294.21%76.30%-87.53%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
57.41%57.52%59.40%61.63%60.99%62.71%
Operating Margin
8.36%8.08%7.69%8.18%6.05%8.99%
Pretax Margin
7.36%8.05%7.21%7.86%6.48%10.68%
Profit Margin
5.03%5.53%5.02%5.60%4.48%7.80%
FCF Margin
6.89%4.41%0.59%10.45%3.49%2.35%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
24.0718.9227.7229.5046.2022.66
Forward PE
18.1816.8919.3321.2234.3618.89
P/FCF Ratio
16.2223.68236.9315.8059.2675.16
PS Ratio
1.121.051.391.652.071.77